Proteomics and the Kidney: Urinary Biomarkers
Chairs:
Marc De Broe, Belgium
Hamid Rabb, USA

• Identification of Urinary Biomarkers of Acute Renal Failure
  Prasad Devarajan, USA
• Urinary Biomarkers in Nephrotic Syndrome
  Tadashi Yamamoto, Japan
• Urinary Proteomics: Barriers to Success
  Visith Thongboonkerd, Thailand

Mechanisms of Mechanosensing
Chairs:
Jurgen Schnermann, USA
Jing Zhou, USA

• Polycystins as Mechanosensors
  Jing Zhou, USA
• TRP Channels
  Marc Freichel, Germany
• Myogenic Response: Degenerin/eNaC
  Nektarios Tavernarakis, Greece
• Mechanosensing of Flow in the Proximal Tubule
  Tong Wang, USA

Unconventional Roles of Aquaporins
Chairs:
Thomas E. Andreoli, USA
Marcelo Morales, Brazil

• Aquaporin 1: CO2 Transport
  Yuehan Zhou, USA
• Aquaporin 1: NO Transport
  Marcela Herrera, USA
• Aquaporin-6: a pH-Sensitive Anion
  Channel
  Masato Yasui, USA

Chronic Inflammation and Fibrosis of the Kidney
Chair: Eric Neilson, USA

• Epithelial-Mesenchymal Transdifferentiation and Renal Fibrogenesis
  Youhua Liu, USA
• Epithelial-Mesenchymal Transdifferentiation in Human Biopsies
  Maria Pia Rastaldi, Italy
• Renin-Angiotensin and Fibrosis
  Robert Zatz, Brazil
• Therapeutic Targets in Fibrosing Renal Diseases
  Jürgen Floege, Germany

Hypoxia and Progression of Kidney Failure
Chairs:
Pierre-Louis Tharaux, France
Masaomi Nangaku, Japan

• Chronic Hypoxia Hypothesis
  Samuel N. Heyman, Israel
• Hypoxia Inducible Factors in the Kidney
  Susan Quaggin, Canada
• Peritubular Capillary Loss and Kidney Disease
  Richard J. Johnson, USA
• Therapy Targeting Hypoxia in the Kidney
  Masaomi Nangaku, Japan

Stem Cells: the Future for Renal Disease
Chair: Niels Olsen, Brazil

• Stem Cell Therapy in Regressing Glomerular Diseases Involving GBM-Podocyte Defects
  Raghu Kalluri, USA
• Stem Cells and Renal Tubules
  Lloyd Cantley, USA
• Stem Cells and Glomeruli
  Enyu Imai, Japan

Genomics and Model Organisms in Understanding Renal Diseases
Chairs:
Friedhelm Hildebrandt, USA
Jorge Toblli, Argentina

• Comprehensive Expression Profiling During Development and Disease: Implications for Novel Treatments
  Melissa Little, Austria
• Zebra Fish
  Ian Drummond, USA
• NPHP Genes in C. Elegans
  Maureen Barr, USA

RAS and VEGF in Development and Renal Diseases
Chairs:
Ariel Gomez, USA
Venkata S. Ram, USA

• Renin-Synthesizing Cells during Kidney Development
  Ariel Gomez, USA
• RAS Mutations in Renal Tubular Dysgenesis
  Marie Claire Gubler, France
• Role of the RAS in the Development of the Ureteric Bud and Renal Collecting System
  Ihor V. Yosypiv, USA
• WT1 and VEGF in Kidney Development
  Jordan Kreidberg, USA

Hereditary Glomerular Diseases
Chairs:
Sergio Mezzano, Chile
Pierre Ronco, France

• Nephrotic Syndrome
  Moin A Saleem, UK
• Nail-Patella Syndrome
  Nine Knoers, The Netherlands
• Familiar Mediterranean Fever
  Rezan Topaloglu, Turkey
• Hereditary Nephritis: from Bench to Bedside
  Jie Ding, P.R. China

Interactive Clinical-Pathologic Discussion: Steroid-Resistant Nephrotic Syndrome
Chairs:
Daniel Cattran, Canada
José Mauro Vieira Jr, Brazil

Pathologist: Luiz A. Moura, Brazil
Clinical Discussant: Giuseppe Remuzzi, Italy

General Nephrology 1
Chairs:
Miguel Cendoroglo Neto, Brazil
Saraladevi Naicker, South Africa

Free Communications

HIV Nephropathy: Changing Epidemiology and Presentation in the New Millennium
Chairs:
Paul L. Kimmel, USA
Eric Daugas, France

• Epidemiology of HIV Nephropathy
  Paul E. Klotman, USA
• Glomerular Disease Associated to HIV
  Paul L. Kimmel, USA
• Dialysis and Transplantation in HIV Patients
  Eric P. Rondeau, France
• Nephrotoxicity of Antiretriviral Therapy
  Antonio Carlos Seguro, Brazil

Novel Treatment Strategies in CKD
Chair: Dick de Zeeuw, The Netherlands

• Antifibrotic Therapy
  Kumar Sharma, USA
• Endothelin Antagonism
  Ariela Benigni, Italy
• GAG’s Intervention
  Giovanni Gambaro, Italy

Chronic Kidney Disease - Human and Experimental Studies
Chairs:
Anupam Agarwal, USA
Ariela Benigni, Italy

Free Communications

Novel Pathways for Targeting and Preventing Diabetic Complications
Chairs:
Eberhard Ritz, Germany
Ana María Cusumano, Argentina

• Inflammatory Pathways
  Steven Shoelson, USA
• Oxidative Stress
  Anupam Agarwal, USA
• Glucose Flux through Polyol and Hexosamine Pathways and AGEs
  Hans-Peter Hammes, Germany
• PPARs
  Bart Staels, France

Utility of Biomarkers for Predicting Outcomes in Dialysis Patients
Chair: Angela Wang, P.R. China

• Utility of Inflammatory and Cardiac Biomarkers in ESRD
  Roberto Pecoits-Filho, Brazil
• Gene Polymorphism in ESRD Patients
  Peter Stenvinkel, Sweden
• Will Proteomics Provide Useful Biomarkers in ESRD Patients?
  Jon Klein, USA
• Depression as a Mortality Predictor in ESRD
  Paul L. Kimmel, USA

Salt and Hypertension in ESRD
Chair: Angela Webster, UK

• Sodium as a Uremic Toxin
  Eberhard Ritz, Germany
• Causes and Consequences of Sympathetic Hyperactivity in ESRD
  Peter J. Blankestijn, The Netherlands
• How to Determine Estimated Dry Weight in Dialysis Patients
  Karel M. L. Leunissen, The Netherlands
• Trials of Different Antihypertensive Agents and Targets in ESRD Patients
  Francesco Locatelli, Italy

New Approaches to Uremic Toxicity
Chair: Norbert Lameire, Belgium

• Classification of Uremic Toxins
  Raymond Vanholder, Belgium
• Linking Uremic Toxins to Cardiovascular Disease
  Carmine Zoccali, Italy
• Oral Sorbent Therapies
  Gerald Schulman, USA
• Hemodiafiltration, promise for the future?
  Peter J. Blankestijn, The Netherlands

The Changing Face of Rejection: Role of Antibodies
Chairs:
Jeremy Chopman, Australia
Maria Cristina Ribeiro de Castro, Brazil

• Antibody Mediated Rejection: Impact and Management
  Heinz Regele, Austria
• ABO Incompatible Renal Transplantation
  Kazuhide Saito, Japan
• Renal Transplantation of the Highly Sensitized Patient
  Khalid Al-Meshari, Saudi Arabia

Immunosuppression: an Update
Chairs:
Alvaro Pacheco-Silva, Brazil
Adel Bakr, USA

• New Drugs
  Helio Tedesco, Brazil
• New Biologicals
  Flavio Vincenti, USA
• What Should be Measured in Trias Designed to Improve Long-Term Outcomes?
  Jeremy Chapman, Australia
• Pharmacokinetics of Immunosuppressive Drugs Revisited
  Elias David-Neto, Brazil

Novel Concepts in Transplantation Immunobiology
Chair:
Barbara Murphy, USA
Jorge Kalil, Brazil

• Co-Stimulatory Pathways: an Update
  Mohamed H. Sayegh, USA
• The Role of Naïve and Memory T Cells in Allograft Rejection and Resistance to Tolerance
  John Iacomini, USA
• Biology of Regulatory T Cell Function
  David Rothstein, USA

New Diagnostic Markers in ARF
Chairs:
Robert Schrier, USA
Nestor Schor, Brazil

• Biomarkers
  Joseph Bonventre, USA
• Cystatin C
  Andreas Kribben, Germany
• Clinical and Experimental Imaging
  Zoltan Endre, New Zealand

ARF in Sepsis
Chairs:
Claudio Ronco, Italy
Timothy Bunchman, USA

• Potential Interventions in Sepsis-Related Acute Renal Failure
  Robert W. Schrier, USA
• Organ Involvement and Dysfunction
  Nestor Schor, Brazil
• Hemodynamic Monitoring and Role of Vasopressors
  Patrick T. Murray, USA
• RRt in Septic ARF
  Ravindra Mehta, USA

Models to Study Acute Kidney Injury
Chairs:
Andreas Kribben, Germany
Carlo Basile, Italy

• Chemokines and Acute Renal Injury
  Reza Abdi, USA
• Schemia
  Bruce A. Molitoris, USA
• Toxins
  Marc De Broe, Belgium

Regulation of Body Phosphate Homeostasis: New Aspects
Chairs:
Heini Murer, Switzerland
Vanda Jorgetti, Brazil

• Na/Pi Cotransporter Regulation: New Insights
  Jürg Biber, Switzerland
• Phosphate Homeostasis: State of Phosphatonins
  Rajiv Kumar, USA
• FGF23 in Pi Homeostasis
  Takashi Shimada, Japan

Gene Silencing
Chairs:
Susan Quaggin, Canada
Luiz F. Onuchic, Brazil

• Use of siRNA in Mammalian Systems
  Yoshitsugu Takabatake, Japan
• RNAi knock down or targeted knockout: pros and cons
  Andras Nagy, Canada
• Conditional Knockout - Cre Recombinase
  Susan Quaggin, Canada
• Conditional Knockout - The Tet System
  Jeffrey Kopp, USA

Kinase Signaling in the Regulation of Ion Transporters and Channels
Chairs:
Gerardo Gamba, Mexico
Nancy Amaral Rebouças, Brazil

• SGK
  Florian Lang, Germany
• WNK’s
  Gerardo Gamba, Mexico
• OSR1 and SPAK
  Eric Delpire, USA

Infectious and Environmental Causes of Renal Disease
Chairs:
Bernardo Rodríguez-Iturbe, Venezuela
John Feehally, UK

• Lead Nephropathy
  Chun-Chen Yu
• Snake Venom Induced Acute Renal Failure
  Emmanuel A. Burdmann, Brazil

New Pathways in Vascular Cell Signaling
Chairs:
Thomas Coffman, USA
Richard Quigg, USA

• The Biological Role of Retinoid-Orphan- Receptors
  Anton Jetten, USA
• Pathways Linking AT1 to Vasomotion
  Giuseppe Lembo, Italy
• Pi3 Kinase: from T Cell Differentiation to Renal Inflammation
  Ana Clara Carrera, Spain
• Wnt in Kidney
  Seppo Vainio, Finland

New Insights into Glomerulonephritis
Chairs:
Jürgen Floege, Germany
Jan J. Weening, The Netherlands

• New Models of Membranoproliferative Glomerulonephritis
  Charles E. Alpers, USA
• Complement Defects in MPGN and HUS
  Marina Noris, Italy
• Pathogenesis of Membranous GN
  Pierre Ronco, France
• Therapy of MPGN and Membranous GN
  Dan Cattran, Canada

Molecular Mechanisms that Underlie Human Renal Malformation
Chairs:
Rémi Salomon
Melissa Little, Australia

• Branching morphogenesis of the ureteric bud
  Jonathan Licht, USA
• GLI3, Pallister Hall Syndrome and Renal Dysplasia
  Norman Rosenblum, Canada
• Pax2 and Renal Hypoplasia
  Paul Goodyer, Canada

Modifier Genes and Ethnic Variations in Renal Development and Disease
Chairs:
Nancy Amaral Rebouças, Brazil
Corinne Antignac, France

• Genetics of Renal Disease in Specific South African Populations
  Lindsay Lambie, South Africa
• Modifier Genes in Polycystic Kidney Disease
  Lisa Guay-Woodford, USA
• Modifier Genes in the Progression of Chronic Renal Failure
  Fabiola Terzi, France
• Genetic Susceptibility to HIV-1- Associated Nephropathy
  Ali Gharavi, USA
• Reduced nephron number and glomerulomegaly in Australian Aborigines
  John Bertram, Australia

Hereditary Diseases and Renal Development
Chairs:
Martin Konrad, Switzerland
Noemia Perli Goldraich, Brazil

Free Communications

Interactive Clinical Case Discussion: Severe Hypertension Refractory to Treatment - Diagnosis and Treatment
Chairs:
Leon F. Ferder, Puerto Rico
José Luño, Spain

Clinical Discussants:
Venkata S. Ram, USA
Sunanda Ram, USA
George Bakris, USA

Tropical Nephrology Symposium
Chairs:
Rubina Naqvi, Pakistan
Kirpal S. Chugh, India

• Natural Medicines Causing Renal Injury
  Vivekanand Jha, India
• The Kidney in Leptospirosis
  Regina Abdulkader, Brazil
• Malaria-Induced Renal Injury
  Visit Sitprija, Thailand
• Schistosomiasis and the Kidney
  Rashad Barsoum, Egypt

Diagnostics and Therapeutic Challenger in Clinical Nephrology
Chairs:
Raul Carlini, Venezuela
Mauricio Younes-Ibrahim, Brazil

• Cholesterol Embolism
  Francesco Scolari, Italy
• Streptococcal Nephritogenicity: Old Data, New Findings
  Bernardo Rodriguez-Iturbe, Venezuela
• Acute Interstitial Nephritis
  Mark A. Perazella, USA
• Multiple Myeloma and Dysproteinemias
  Paul W. Sanders, USA

Can CKD Regress?
Chairs:
Giuseppe Remuzzi, Italy
Roberto Zatz, Brazil

• Regression of Diabetic Nephropathy: How Far Can it Go, How Long Must it Take?
  Paola Fioretto, Italy
• Suppressors of the Renin-Angiotensin System and Regression of Progressive Nephropathies
  Christos Chatziantoniou, France
• Extracellular Matrix and Progressive Nephropathies: Molecular Targets in the Quest for Regression
  Agnes Fogo, USA
• Hepatocyte Growth Factor Therapy: Can it Reverse Diabetic Nephropathy?
  Josep Maria Grinyó, Spain

Predictors of CV Risk in Renal Disease
Chairs:
Tomas Berl, USA
Ezequiel Bellorin-Font, Venezuela

• Albumin as a Predictor of CV and Renal Disease
  Bo Feldt-Rasmussen, Denmark
• Lipid Abnormalities in Renal Disease: Do They Contribute to Progression?
  Moshe Levi, USA
• How Does Renal Disease Contribute to CV Risk?
  Jonathan Himmelfarb, USA
• How Do These Risk Factors Interact?
  Dick de Zeeuw, The Netherlands

Genetic Contributions to HT
Chairs:
Fiona Karet, UK
Sérgio Mezzano, Chile

• The Role of ENaC
  Bernard Rossier, Switzerland
• Mechanisms of Hypertension in CKD: Molecular Studies in Acquired and Deleted Proteins
  Gary Desir, USA
• Gene-Targeting Studies of the Renin-Angiotensin System
  Thomas Coffman, USA
• Genetics of Hypertension in Humans: Multiple Gene Alleles Contribute to Hypertension
  Daniel O’Connor, USA

Selected Outstanding ESRD Abstracts
Chairs:
Angela Wang, P.R. China
Giovanni Strippoli, Italy

Free Communications

The Global Kidney Disease Epidemic
Chair: Adeera Levin, Canada

• KDIGO and the Global Implications of Kidney Disease
  Norbert Lameire, Belgium
• Is the Incidence of ESRD Leveling Off?
  Allan J. Collins, USA
• The Twin Epidemics of CKD and ESRD: Real or Iatrogenic?
  Richard Glassock, USA
• Managing the CKD/CVD/ESRD Continuum
  Adeera Levin, Canada

Phosphorus, Calcium, and PTH: Trials and
Observational Studies
Chair: Jorge B. Cannata-Andia, Spain

• Pathophysiology of Vascular Calcification
  Cecilia Giachelli, USA
• Non-Calcium-Containing Phosphorus Binders
  Sharon Moe, USA
• Calcimimetics
• Bone Anabolic Agents
  Keith A. Hruska, USA

Chronic Allograft Nephropathy: Causative Factors and Therapeutic Approaches
Chairs:
David Rush, Canada
J. Harold Helderman, USA

• Molecular Phenotypes
  Philip O’Connell, Australia
• Chronic Antibody Mediated Rejection: Implications for Long-Term Graft Outcome
  Robert Colvin, USA
• Strategies to Prevent Chronic Allograft Nephropathy
  Anil Chandraker, Australia

Update on Pediatric Transplantation
Chairs:
Jorge Ferraris, Argentina
Mitra Mahdavi, Iran

• What are the Options for Immunosuppression in Pediatrics?
  William Harmon, USA
• Disease Recurrence in Pediatric Tx
  Pierre Cochat, France
• Long-Term Outcomes of Pediatric Tx
  Stephen McDonald, Australia
• Unique Complications in Pediatric Renal Transplantation
  Richard N. Fine, USA

Experimental Transplantation and Anti-Donor Antibodies
Chair: Stephen McDonald, Australia

Free Communications

Advances in the Biology of the Tubular Epithelium and Interstitium in ARF
Chairs:
Marc De Broe, Belgium
Joseph V. Bonventre, USA

• Inflammation
  Hamid Rabb, USA
• The Role of Hypoxia-Inducible Gene Expression
  Kai-Uwe Eckardt, Germany
• Heat Shock Proteins
  Scott Van Why, USA

ARF in Children
Chairs:
Franz Schaefer, Germany
Sharon Andredi, USA

• Causes of ARF in Children
  Timothy Bunchman, USA
• Risk Factors
  Stuart L. Goldstein, USA
• Non-Dialytic Management of ARF in Children
  Sharon Andreoli, USA
• Dialytic Management
  Felipe Cavagnaro, Chile

Metabolic Control of the Critically Ill with ARF
Chairs:
Wilfred Druml, Austria
Andrew Davenport, UK

• Glucose Control
  Miet Schetz, Belgium
• Electrolyte, Acid-Base
  Peter Gross, Germany
• Nutrition
  Emmanuel A. Burdmann, Brazil

Fetal Programming and the Kidney
Chair: Oscar Pavao dos Santos, Brazil

• Prenatal Malnutrition
  Terezila Machado Coimbra, Brazil
• Developmental Effects of Diabetes
  Andreas Plagemann, Germany
• Programming of Renal Function in Utero
  Russell Brown, Australia

Aldosterone: New Aspects and Mechanisms
Chair: Celso Caruso Neves, Brazil

• Aldosterone in Chronic Kidney and Heart Disease: an Overview
  Thomas H Hostetter, USA
• Cyclosporine Toxicity
  Norma A. Bobadilla, Mexico
• Vascular Effects of Aldosterone
  Ole Skott, Denmark
• Aldosterone and the Fibrinolytic System
  Nancy Brown, USA

Role of Nuclear Receptors in Lipid Metabolism, Inflammation, Fibrosis and Cancer
Chairs:
Moshe Levi, USA
Monica P. Revelo, USA

• Sterol- and Carbohydrate-Response Element-Binding Proteins
  Catherine Postic, France
• Nuclear Oxysterol (LXR) and Bile Acid Receptors (FXR)
  Moshe Levi, USA
• PPARs in Glucose and Lipid Metabolism
  Frank J. Gonzalez, USA

Oxidative Stress
Chair: Sudhir V. Shah, USA

• Oxidative Stress and Hypertension
  Christopher Wilcox, USA
• Oxidative Stress in Chronic Renal Failure
  Nick Vaziri, USA
• Oxidative Stress in Human Hypertension
  Rhian M. Touyz, Canada

New Insights into the Role of Specific Cell Types in the Kidney
Chair: Dontscho Kerjaschki, Austria

• Lymphatics
  Dontscho Kerjaschki, Austria
• Podocytes
  Larry Holzman, USA
• Parietal Epithelial Cells
  Marcus Moeller, Germany
• Endothelial Cells
  Danilo Fliser, Germany

Autoimmunity and Kidney Disease
Chairs:
Vicki Rubin-Kelley, USA
Jan Willem Cohen-Tervaert, The Netherlands

• Developmental origins of early hematopoietic stem cells
  Amin Arnaout, USA
• The Power of the Parenchyma (Epithelial – Leukocyte Interactions)
  Vicki Rubin-Kelley, USA
• Renal Pathology of Lupus Nephritis
  Luiz A. Moura, Brazil
• Clinical Trials in Lupus
  David R.W. Jayne, USA

Bioengineering in the Treatment of Renal and Urological Diseases
Chairs:
Raghu Kalluri, USA
David Humes, USA

• Mesenchymal Stem Cells and their Renal Potential
  Takashi Yokoo, Japan
• Renal Assist Device: Will It Ever Be Transplantable or Applicable to Chronic Disease?
  David Humes, USA
• Bioengineering Ureters, Bladders and Vas Deferens
  Julie Campbell, Australia

Polycystic Kidney Disease
Chairs:
Jing Zhou, USA
Vicente Torres, USA

• Wnt Signaling and Cyst Formation
  Gerd Walz, Germany
• A Transcriptional Network in Polycystic Kidney Disease
  Marco Pontoglio, France
• Molecular and Cell Pathogenesis of ARPKD
  Luiz F. Onuchic, Brazil
• Bardet-Biedl Syndrome
  Philip Beales, UK
• Nephronophthisis: Gene Identification Towards a Unifying Theory of Cystic Kidney Diseases
  Friedhelm Hildebrandt, USA
• Medullary Cystic Kidney Disease
  Luca Rampoldi, Italy
• Polycystic Kidney Disease: Mechanisms and Therapeutic Insights
  Vicente Torres, USA